Form 8-K - Current report:
SEC Accession No. 0000914475-23-000065
Filing Date
2023-10-05
Accepted
2023-10-05 07:02:38
Documents
14
Period of Report
2023-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20231005.htm   iXBRL 8-K 22769
2 EX-99.1 nbix2023105-exhibit991.htm EX-99.1 33669
6 GRAPHIC nbix-20231005_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-23-000065.txt   240053

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20231005.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20231005_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20231005_pre.xml EX-101.PRE 12514
8 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20231005_htm.xml XML 2713
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 231309798
SIC: 2836 Biological Products, (No Diagnostic Substances)